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Purpose:  Once  lung  cancer  is  detected  due  to  clinical  symptoms  or by being  visible  on  chest  X-ray,  it
is usually  high  stage  and  non-operable.  In order  to improve  mortality  rates  in  lung cancer,  low-dose  CT
(LDCT)  screening  of “high  risk”  individuals  is gaining  popularity.  However,  the rate  of  malignancy  in LDCT
detected  sub-centimetre  lung  nodules  is  not  clear.  We  aimed  to  analyze  surgically  resected  specimens  in
this patient  group  to  explore  cost  effectiveness  and  recommendations  for clinical  management  of these
nodules.
Material  & methods:  Our  hospital  pathology  database  was  searched  for sub-centimeter  lung  nodules
detected  by LDCT  screening  which  were  resected.  The  patient  demographics  were  collected  and  the
radiologic  and  pathologic  characteristics  of  those  nodules  were  analyzed.
Results:  From  the records,  44  patients  with  46 resected  subcentimetre  nodules  were identiﬁed.  Patients
were  selected  for  surgery  based  on an  irregular  shape,  growth  in size  during  follow  up, family  history  of
lung  cancer  or personal  history  of cancer  of  other  sites,  previous  lung  disease,  smoking  and personal  anxi-
ety.  Of  the  44 patients,  33  were  women  and the ages  ranged  from  43  to 76  years  (56.75  ±  8.44).  All  nodules
were  equal  to, or less  than  10 mm  with  a  mean  diameter  of  7.81 ±  1.80  mm  (SD).  Out of  46  nodules,  the
pathological  diagnoses  were:  invasive  adenocarcinoma  (ACa)  in  4 (8.7%);  adenocarcinoma  in  situ  (AIS)
or atypical  adenomatous  hyperplasia  (AAH)  in 29 (63%);  benign  ﬁbrosis/ﬁbrotic  scar  with  inﬂammation
or  calciﬁcation  in  12 (26.1%);  an  intrapulmonary  benign  lymph  node  in  1 (2.2%).  Of  the  ACa,  AIS  and  AAH
groups  (a total  of  31  patients),  77%  were  women  (24  vs. 7).  The  cancer  or  pre-cancer  nodules  (ACa,  AIS  and
AAH) tended  to  be  larger  than  benign  ﬁbrotic  scars  (P  = 0.039).  Amongst  all characteristics,  signiﬁcant  sta-
tistical differences  were  found  when  the following  radiological  features  were  considered:  reconstructed
nodule  shape  (P  =  0.011),  margin  (P =  0.003)  and  ground  glass  pattern  (P = 0.000).  The  patient’s  age,  the
axial  morphology  of the  lesion,  relationship  to major  vessels  or visceral  pleura  and  location  within  the
lung  parenchyma  were  not  predictive  of  the  pathologic  diagnosis.  Only  one  of the  31 patients  with  a
cancer  or pre-cancer  nodule  was  a  smoker.
Conclusion:  ACa,  AIS  and AAH  nodules  detected  on LDCT  included  more  women  (77%) than  men  in our
cohort.  Smoking  as  inclusive  criteria  for  LDCT  screening  of  lung  cancer  needs  to  be further  evaluated  in
the  Chinese  population.  The  reconstructed  nodule  shape, density  and  margin  may  help  radiologists  to
identify  small  cancer  and pre-cancer  nodules  from  benign  conditions.
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Globally, lung cancer has the highest mortality rate [1]. By the
time lung cancer is clinically symptomatic or can be detected by
chest X-ray, it is already at a high stage and is not curable [2,3]. In
China, due to the concern of the relationship between air pollution
and lung cancer and in the hope to catch the disease at an early
stage, LDCT screening of “high risk” individuals is gaining in popu-
larity [4]. However, the pathologic characteristics and particularly,
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Fig. 1. 63 year old female. A. Right lower lobe opacity; B. Reconstructed image of 0.67 mm section thickness using high-frequency algorithms and displayed at standard
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ookwire localizatio before VATS. G: Histology HE × 400 showing AAH.
he rate of malignancy in CT detected sub-centimeter lung nod-
les is not clear [5–7]. Analysis of surgically resected specimens
n this patient group may  provide insights into the demographic
haracteristics of these sub-centimeter nodules, the cost effective-
ess of such screening and, importantly, recommendations on the
ubsequent clinical management.
. Material & methods
From July 2013 to March 2015, 44 asymptomatic patients with
6 sub-centimeter lung nodules (two patients each had 2 nod-
les) that were detected by LDCT screening and subsequently
nderwent CT-guided hook-needle localization and video-assisted
horacoscopic surgery (VATS) were retrospectively selected from
he pathology database of Northern Campus of Shanghai No. 9 Peo-
le’s Hospital. The patient’s demographics and the radiologic and
athologic characteristics of these nodules were collected from
he records and included gender, age, nodule location, size, shape,
ensity, relation to major vessels, relation to visceral pleura, his-
ory of smoking and the major reasons for surgery. CT scanning
rilliance-64, MX-8000 IDT CT scanner (Philips Medical Systems,
leveland, OH) was acquired at the end of inspiration and per-
ormed from the thoracic inlet to the upper portion of the kidneys.
he scanning parameters were as follows: 120 kVp, 40–60 mAs,
nd a pitch of 0.875. Thin-section CT images were reconstructed
nto 0.675 mm section thicknesses using high-frequency algo-
ithms and displayed at standard window setting (width, 1600 HU;howing irregular border and micro vasculature passing though. E & F:CT-guided
level,−400 HU). In some cases, follow-up CT scans were performed
at 3-, 6- and 12- months. All CT images were anonymized and
reviewed by two radiologists. The image analyses were based
on the 2013 recommendations by the Fleischner Society [7,8].
The following thin-section reconstruction CT measurements were
recorded: lesion size, distance to pleura, pulmonary location, shape
on transverse and reconstruction imaging (round or oval, polyg-
onal, irregular), margin (smooth, lobulated, spiculated), border
(well-deﬁned, ill-deﬁned), density(solid opacity, mixed ground-
glass, pure ground-glass), relation to vascular structure (pass
through, convergence, unrelated). Lesion size was measured based
on the average of long and short axial dimensions. The distance to
pleura was deﬁned between the center of the lesion and visceral
pleural. Patients all underwent CT-guided hook-needle localiza-
tion of the suspected nodules (PAJUNK, Mammography, Germany,
275S090120S 20G × 120 mm)  before VATS. At the time of wedge
resection, frozen sections performed for initial diagnosis. All spec-
imens were then submitted for permanent section with formalin
ﬁxation and parafﬁn embedding for ﬁnal diagnosis. All diagnoses
were conﬁrmed by 2 pathologists (Figs 1–4 ).
Statistical analysis was  performed using SPSS version 19.0. The
independent sample t test was  used for continuous variables, such
as age, lesion size and distance to pleura. The chi-square test was
used for categorical data to compare CT image ﬁndings. A value
of P < 0.05 was considered statistically signiﬁcant. Due  to the sub-
jectivity of the differential diagnostic criteria, nodules previously
diagnosed as AAH and AIS were combined into one group for sta-
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Fig. 2. 46 year old female. A. Right lower lobe opacity; B, C. Reconstructed image of 0.67 mm section thickness using high-frequency algorithms and displayed at standard
window setting showing solid opacity. D. Post CT-guided hookwire localizatio VATS histology diagnosis is AIS (HE × 400).
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cig. 3. 63 year old man. CT screen show left lower lobe lung irregular opacity. B. one
as  speculated shape, ill-deﬁned boarder and uneven density. C. wedge resection an
istical analysis. There were 29 nodules in this group with, only
wo <5 mm;  based on current WHO  criteria, the majority of these
odules are qualify for the diagnosis of AIS .
. ResultsAs shown in Tables 1 and 2, Patients were selected for surgery
ue to the following reasons: growth in size during the 3–12
onth follow up periods (5 cases); family history of lung cancer (2
ases); personal history of cancers of other sites (11 cases); previ- later, follow up CT show the lesion is increasing in size and density. The lesion also
equent lobectomy show well differentiated invasive adenocarcinoma (H&E × 400).
ous chronic lung disease, including chronic bronchitis and COPD (8
cases); smoking (1 case) and for many cases, personal anxiety about
the CT detected lung nodules played a signiﬁcant role (19 cases).
All resected nodules were also classiﬁed by radiologists to be suspi-
cious based on their experience. Of the 44 patients, 33 were women
and 11 were men, age range 43–76 years (56.75 ± 8.44 SD). Of the
46 nodules (two patients had 2 nodules), pathological diagnoses
were: invasive adenocarcinoma (ACa) in 4 (8.7%); adenocarcinoma
in situ (AIS) and atypical adenomatous hyperplasia (AAH) in 29
(63%); benign ﬁbrosis/ﬁbrotic scar with inﬂammation or calciﬁca-
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Table 1
Case summary.
Final pathology diagnosis Gender Age Location Reason of
Operation
Size (mm) Distance to
pleura
Transverse
Shape
Reconstructed
Shape
Margin Border Density Vascularity
AAH & AIS 1 f 48 Right Upper Anxiety 9.90 18.00 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
2  f 46 Right Lower Anxiety 3.50 5.30 Round/oval Polygonal Lobular Well-deﬁned Part-solid GGO Pass through
3  f 52 Right Upper Enlarged 10.00 7.30 Round/oval Irregular Lobular Ill-deﬁned Part-solid GGO Convergence
4  f 68 Left Upper Thyroid CA 9.20 10.60 Irregular Polygonal Speculated Well-deﬁned Part-solid GGO Convergence
5  m 51 Right Upper Hx of Lung disease 10.00 20.90 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Pass through
6  f 49 Left Lower Thyroid CA 7.60 6.30 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
7  f 55 Right Upper Anxiety 7.30 11.40 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Pass through
8  f 53 Right Lower Smoking 9.00 5.50 Round/oval Round/oval Lobular Well-deﬁned Part-solid GGO Pass through
9  f 53 Left Lower Anxiety 6.30 5.90 Polygonal Polygonal Lobular Well-deﬁned Part-solid GGO Pass through
10  f 70 Left Upper Breast CA 8.60 12.30 Polygonal Polygonal Lobular Well-deﬁned Pure GGOs Convergence
11  m 68 Right Upper Anxiety 8.90 6.40 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Pass through
12  . . Right Upper 5.00 23.90 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
13  f 54 Right Upper Family Hx lung CA 8.30 26.50 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Pass through
14  m 51 Left Upper Family Hx lung CA 9.90 12.30 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Convergence
15  f 48 Right Upper Anxiety 7.70 17.20 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Convergence
16  f 52 Right Upper Anxiety 8.80 4.20 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Convergence
17  f 49 Left Upper Anxiety 7.00 19.50 Polygonal Polygonal Lobular Well-deﬁned Pure GGOs Unrelated
18  f 67 Left Lower Hx of Lung disease 7.00 5.80 Irregular Irregular Lobular Well-deﬁned Pure GGOs Pass through
19  f 75 Left Lower Hx of Lung disease 9.20 4.40 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Convergence
20  f 52 Right Lower Hx lung CA 9.40 41.80 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
21  m 64 Left Upper Enlarged 10.00 28.90 Polygonal Polygonal Lobular Well-deﬁned Part-solid GGO Convergence
22  f 51 Left Upper Anxiety 4.80 15.90 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
23  . . Left Upper 7.20 29.00 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Unrelated
24  f 55 Right Lower Anxiety 5.10 7.20 Polygonal Polygonal Lobular Well-deﬁned Pure GGOs Unrelated
25  f 63 Right Middle Hx of Lung disease 5.40 9.70 Round/oval Round/oval Lobular Well-deﬁned Solid opacity Unrelated
26  f 54 Left Lower Anxiety 8.20 13.60 Polygonal Polygonal Lobular Well-deﬁned Pure GGOs Pass through
27  f 49 Left Lower Anxiety 9.30 14.00 Polygonal Irregular Lobular Well-deﬁned Pure GGOs Convergence
28  m 50 Right Lower Anxiety 7.70 16.50 Round/oval Round/oval Lobular Well-deﬁned Part-solid GGO Convergence
29  f 62 Right Lower Anxiety 8.50 23.00 Irregular Irregular Lobular Well-deﬁned Part-solid GGO Convergence
Total  (N) N 27 27 29 27 29 29 29 29 29 29 29 29
Fib  & ch inf 1 f 53 Right Lower Hx of Lung disease 7.60 19.30 Polygonal Irregular Lobular Well-deﬁned Part-solid GGO Convergence
2  f 47 Right Lower Hx of Ovarian CA 4.90 6.90 Polygonal Polygonal Spiculated Well-deﬁned Part-solid GGO Convergence
3  f 51 Right Lower Hx of Lung disease 8.50 8.80 Irregular Irregular Lobular Well-deﬁned Solid opacity Unrelated
4  m 56 Left Lower Hx of Lung disease 8.50 14.20 Polygonal Irregular Spiculated Well-deﬁned Solid opacity Convergence
5  f 54 Left Lower Hx of Breast CA 8.30 9.20 Polygonal Irregular Lobular Well-deﬁned Solid opacity Pass through
6  f 48 Left Lower Hx of Breast CA 5.50 3.50 Polygonal Polygonal Lobular Well-deﬁned Part-solid GGO Convergence
7  f 71 Right Upper Hx lung CA 8.60 5.60 Irregular Irregular Lobular Ill-deﬁned Pure GGOs Convergence
8  m 76 Left Lower Hx of Lung disease 6.80 9.90 Round/oval Round/oval Lobular Well-deﬁned Part-solid GGO Pass through
9  m 65 Left Upper Anxiety 4.70 9.80 Round/oval Irregular Lobular Well-deﬁned Solid opacity Unrelated
10  f 43 Right Middle Hx of Breast CA 9.90 6.20 Irregular Irregular Spiculated Ill-deﬁned Part-solid GGO Convergence
11  f 67 Right Upper Enlarged 8.50 11.30 Round/oval Round/oval Lobular Well-deﬁned Solid opacity Convergence
Total  (N) 11 11 11 11 11 11 11 11 11 11 11 11
ACa  1 f 56 Right Upper Anxiety 9.60 8.10 Irregular Irregular Lobular Well-deﬁned Part-solid GGO Pass through
2  m 58 Right Middle Enlarged 10.00 14.10 Polygonal Polygonal Spiculated Well-deﬁned Part-solid GGO Pass through
3  f 53 Left Upper Anxiety 8.70 24.30 Round/oval Round/oval Lobular Well-deﬁned Pure GGOs Pass through
4  m 63 Left Lower Enlarged 10.00 3.00 Polygonal Polygonal Spiculated Well-deﬁned Part-solid GGO Convergence
Total  (N) N 4 4 4 4 4 4 4 4 4 4 4 4
Benign  LN 1 f 58 Right Lower Anxiety 5.60 7.30 Round/oval Round/oval Lobular Well-deﬁned Solid opacity Unrelated
Total  (N) N 1 1 1 1 1 1 1 1 1 1 1 1
Cal.  1 m 69 Right Upper Anxiety 5.10 7.00 Polygonal Irregular Lobular Well-deﬁned Part-solid GGO Unrelated
Total  (N) N 1 1 1 1 1 1 1 1 1 1 1 1
Total  N 44 44 46 46 46 46 46 46 46 46 46 46
Abbreviations: CA: carcinoma. ACa: invasive adenocarcinoma. AIS: adenocarcinoma in situ. AAH: atypical adenomatous hyperplasia. LN: lymph node. Cal: calciﬁcation. Abs: abscess. Fib & Ch Inf.: ﬁbrosis & chronic inﬂammation.
Hx  of: history of.
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Fig. 4. 75 year old man with history of COPD. A. Screening CT show left lower lobe dense opacity. B & C. Reconstructed crown and saggital images show irregular speculated
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ion in 12 (26.1%); intrapulmonary benign lymph node in 1 (2.2%).
f the ACa, AIS and AAH groups (a total of 31 patients), 77% were
omen (24 vs. 7). Interestingly, only one out of 31 patients in this
roup was a smoker.
Amongst all characteristics, signiﬁcant statistical differences
ere found between the ACa/AIS/AAH nodule group and benign
odule group when the following radiological features were con-
idered: reconstructed nodule shape (P = 0.011), margin (P = 0.003)
nd ground glass opacity density (P = 0.000). The patient’s age,
he axial morphology of the lesion, relationship to major ves-
els or visceral pleura and location of the nodule within the lung
arenchyma were not predictive of the pathologic diagnosis. Only
ne of the 31 patients with a cancer or pre-cancer nodules was a
moker. All 46 nodules were equal or less than 10 mm,  mean ± SD
s 7.81 ± 1.81 mm.  Respectively, mean size was, adenocarcinoma,
.57 mm,  AIS, 8.16 mm and AAH, 4.15 mm,  although there was
o statistical difference in size among all groups, cancer and pre-
ancer nodules put together as one group tended to be larger thanwire VATS wedge resection show ﬁbrous scare)H&E × 400).
benign ﬁbrotic scars (P = 0.039). The average distance between the
nodules to the pleura was  9.18 mm,  and there was no statistical
difference in the distance to the pleura.
3. Discussion
This is a retrospective study based on a single hospital pathology
practice. We  focused on surgically resected lung nodules that were
detected by LDCT screening of asymptomatic individuals. Although
the study is limited by the relatively small sample size and single
centre practice, there were some interesting ﬁndings. First, among
the 31 patients with cancer and pre-cancer conditions (i.e. AAH, AIS
and ACa), 24 were female (77%) and 7 were men. This is in contrast
to the prevailing paradigm that lung cancer is a male predomi-
nant disease [1]. It is possible that the pre-cancerous/pre-invasive
(AAH and AIS) nodules grow very slowly and are therefore more
likely to be included in this group of sub-centimeter incidental
nodules. It is also possible that female patients were more likely
228 X. Hu et al. / European Journal of Rad
Table 2
Comparison of LDCT image characteristics between cancer/pre-cancer lesions (ACa,
AIS, AAH) and Other benign lesions (Fib., LN, Cal).
Others (13) ACa/AIS/AAH (33) P value
Shape Transverse
Irregular 3 4 0.181
23.1% 12.1%
Polygonal 6 9
46.2% 27.3%
Round/oval 4 20
30.8% 60.6%
Shape Reconstructed
Irregular 28 5 0.011
61.5% 15.2%
Polygonal 2 10
23.1% 30.3%
Round/oval 3 18
23.1% 54.5%
Margin
Smooth 7 5
53.8% 15.2% 0.003
Lobular 3 25
23.1% 75.8%
Speculated 3 3
23.1% 9.1%
Border
Ill-deﬁned 2 1 0.188
15.4%. 3.0%
Well-deﬁned 11 32
84.6% 97.0%
Density
Part-solid GGO 6 11
46.2% 33.3% 0.000
Solid opacity 6 1
46.2% 3.0%
Pure GGOs 1 21
7.7% 63.6%
Surrounding vascular
Pass through 2 12 0.385
15.4% 36.4%
Convergence 7 12
53.8% 36.4%
Unrelated 4 9
30.8% 27.3%
Location
Left lower 4 7
30.8% 21.2% 0.640
Left  upper 1 8
7.7% 24.2%
Right middle 1 2
7.7% 6.1%
Right lower 4 6
30.8% 18.2
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[Right upper 3 10
23.1% 30.3%
o request removal of their incidental lung nodules due to anx-
ety. Genetic differences from the western population, on which
uch of the present studies are based, may  explain our ﬁndings
9]. It is known that EGFR mutations in lung cancer are more com-
on  in women, in patients who have never smoked tobacco and
n East Asians [10], and there is some evidence that EGFR muta-
ions are over-represented in more low-grade lung cancers [11].
owever, we do not have this data for our group. Another interest-
ng ﬁnding was that of the 31 patients with cancer and pre-cancer
odules, only one (a woman), was a smoker. The inclusion crite-
ia “at least a 30 pack-year smoking history who  smoke or quit
moking <15 years ago” is used in most LDCT screening programs
12–14], which are based on data generated from North America
r European population. Therefore our ﬁndings raise an important
uestion – will screening programs based on these inclusion criteria
[
[iology Open 3 (2016) 223–229
exclude a signiﬁcant proportion of the population that may  beneﬁt
from screening, at least in the Chinese population. Most published
studies indicate that the malignancy ratio in LDCT detected lung
nodules is very small with a false positive rate of approximately
96% [12–16], but these papers are based on Western populations
and we  do not know how applicable this is in our population.
Currently, there are no recommendations or guidelines for LDCT
lung cancer screening in China. Due to the concerns that air pol-
lution is a risk factor for lung cancer, many companies include
LDCT screening as part of an employee’s annual physical exam,
as is the case for the patients in our study. The patients were
selected for surgery based on a combination of the experience
of the radiologists and surgeons experiences and the individual
patient’s anxiety level. It is clear that more studies investigat-
ing different screening inclusion criteria and standardized “lung
nodule management algorithms” are necessary to determine the
optimal practice in the Chinese population. The newly published
NELSON data concluded that measurement of nodule volume-
try may  provide better prediction on the risk of incidental lung
nodules [17]. Our study also showed that reconstructed nodule
shape, lobulated margin and ground glass density on 0.67 mm  sec-
tion thickness scans using high-frequency algorithms displayed
at standard window setting may  help to identify high risk nod-
ules.
4. Conclusion
In conclusion, although this was  a relatively small study from
a single center, our ﬁndings suggest that the current published
inclusion criteria for LDCT screening for lung cancer in China might
exclude a signiﬁcant number of patients who  are at risk. Further
studies are required in this area.
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